Jokl, E.; Llewellyn, J.; Simpson, K.; Adegboye, O.; Pritchett, J.; Zeef, L.; Donaldson, I.; Athwal, V.S.; Purssell, H.; Street, O.;
et al. Circadian Disruption Primes Myofibroblasts for Accelerated Activation as a Mechanism Underpinning Fibrotic Progression in Non-Alcoholic Fatty Liver Disease. Cells 2023, 12, 1582.
https://doi.org/10.3390/cells12121582
AMA Style
Jokl E, Llewellyn J, Simpson K, Adegboye O, Pritchett J, Zeef L, Donaldson I, Athwal VS, Purssell H, Street O,
et al. Circadian Disruption Primes Myofibroblasts for Accelerated Activation as a Mechanism Underpinning Fibrotic Progression in Non-Alcoholic Fatty Liver Disease. Cells. 2023; 12(12):1582.
https://doi.org/10.3390/cells12121582
Chicago/Turabian Style
Jokl, Elliot, Jessica Llewellyn, Kara Simpson, Oluwatobi Adegboye, James Pritchett, Leo Zeef, Ian Donaldson, Varinder S. Athwal, Huw Purssell, Oliver Street,
and et al. 2023. "Circadian Disruption Primes Myofibroblasts for Accelerated Activation as a Mechanism Underpinning Fibrotic Progression in Non-Alcoholic Fatty Liver Disease" Cells 12, no. 12: 1582.
https://doi.org/10.3390/cells12121582
APA Style
Jokl, E., Llewellyn, J., Simpson, K., Adegboye, O., Pritchett, J., Zeef, L., Donaldson, I., Athwal, V. S., Purssell, H., Street, O., Bennett, L., Guha, I. N., Hanley, N. A., Meng, Q.-J., & Piper Hanley, K., on behalf of the ID-LIVER Consortium.
(2023). Circadian Disruption Primes Myofibroblasts for Accelerated Activation as a Mechanism Underpinning Fibrotic Progression in Non-Alcoholic Fatty Liver Disease. Cells, 12(12), 1582.
https://doi.org/10.3390/cells12121582
